Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
XCUR
XCUR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XCUR News
Exicure (XCUR) to Present 89.7% Success Rate Data at ASTCT Meeting
Jan 21 2026
Newsfilter
Exicure Stock Rises 41% Following Positive Phase 2 Results for Multiple Myeloma Treatment
Dec 09 2025
NASDAQ.COM
Crude Oil Falls 1%; AutoZone Stock Declines Following Q1 Earnings Report
Dec 09 2025
Benzinga
Exicure Soars Following Promising Cell-Enhancing Outcomes in Blood Cancer Study
Dec 09 2025
Benzinga
Dow Rises More Than 100 Points as Campbell's Reports Positive Earnings
Dec 09 2025
Benzinga
What Critics Misunderstand About AI — and Why These Stocks Will Continue to Rise Despite Concerns
Dec 09 2025
MarketWatch
Mama's Creations Stock Rises Over 13%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 09 2025
Benzinga
Exicure Rises Following Burixafor Trial Results in Multiple Myeloma
Dec 09 2025
NASDAQ.COM
After-Hours Stock Surge: Exicure Leads with 72% Increase, Followed by Wave Life and Assembly Biosciences
Dec 09 2025
NASDAQ.COM
Exicure Reports 90% Success in Phase 2 Trial for Burixafor in Hematologic Diseases
Dec 08 2025
Globenewswire
Exicure Reports 90% Success in Phase 2 Trial of Burixafor for Multiple Myeloma
Dec 08 2025
Newsfilter
Exicure, Inc. Reports Q3 Loss of $2.44 Million
Nov 08 2025
NASDAQ.COM
Stocks of MODD, GALT, XCUR, PEPG, and BSGM Surge in After-Hours Trading Following Clinical Developments and Strategic Actions
Sep 12 2025
NASDAQ.COM
Exicure Posts Wider Loss in Fiscal Q2
Aug 08 2025
NASDAQ.COM
Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements
Aug 04 2025
Newsfilter
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Jun 30 2025
TipRanks
Show More News
